ProNAi to Present at the 33rd Annual J.P. Morgan Healthcare Conference

 Vancouver, BC and Plymouth, MI – January 12, 2015. ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi® platform, today announced that it has been invited to present at the 33rd Annual J.P. Morgan Healthcare Conference being held this week in San Francisco. Dr. Nick Glover, President and CEO of ProNAi, will provide an update on the Company’s development program for its lead DNAi therapeutic, PNT2258, on January 15, 2015 at 11:30 a.m. PST in room Elizabethan D.

Read more:  ProNAi to Present at the 33rd Annual J.P. Morgan Healthcare Conference